Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia
Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the reduction of LDL-cholesterol level after
treatment with 50 mg per day of lapaquistat acetate once daily (QD).